Related Experiment Video
Updated: Apr 29, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Depressive symptoms are associated with fasting insulin resistance in obese youth
T S Hannon1, Z Li, W Tu
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA; Children's Health Services Research, Indiana University School of Medicine, Indianapolis, Indiana, USA; Section of Pediatric Endocrinology & Diabetology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Background:
In adults, depressive symptoms are positively associated with insulin resistance.
Objective:
To determine whether an association exists between depressive symptoms and markers of insulin resistance in youth.
Methods:
This study used a retrospective review of data from an obesity clinic. We evaluated the association between depressive symptoms (Children's Depression Inventory, CDI) and fasting insulin and homeostatic model assessment-insulin resistance (HOMA-IR) in obese youth (n = 207, age 10-18 years). Individuals with lower vs. higher CDI T-scores (<65 vs. ≥65) were compared; this cut-point is accepted as indicating the possibility of clinical depression. Multiple linear regression was used to evaluate relationships between CDI T-scores and insulin resistance.
Results:
Fasting insulin and HOMA-IR values were 40% higher in patients with higher CDI T-scores (P = 0.04). After accounting for gender, race, age and body mass index, CDI T-score remained associated with HOMA-IR, although the strength of the association was small (b = 0.007, P = 0.049).
Conclusions:
Relationships between depressive symptoms and insulin resistance should be considered when evaluating obese youth.
More Related Videos
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
Type I Diabetes III: Clinical Manifestations
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Metabolic States of the Body: Fasting and Starvation
Type II Diabetes II: Pathophysiology
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...